Welcome to our dedicated page for Trilogy Metals SEC filings (Ticker: TMQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Trilogy Metals Inc. (TMQ) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, including Form 8-K current reports, shelf registration statements and related prospectus supplements. As a metal exploration and development company listed on NYSE American, Trilogy uses these filings to report material events tied to its Upper Kobuk Mineral Projects (UKMP) in Alaska, capital-raising programs, strategic transactions and financial results.
Form 8-K filings for Trilogy Metals cover topics such as entry into equity distribution agreements for at-the-market (ATM) offerings, the establishment and replacement of shelf registration statements on Form S-3, and the completion or termination of prior ATM programs. These documents detail the aggregate amounts of common shares that may be sold, the agents involved, commission structures and the legal framework governing the offerings. Other 8-Ks furnish press releases reporting quarterly financial results, providing investors with an official record of net losses, operating expenditures and cash positions as described by the company.
Trilogy also files 8-Ks to disclose project-related and strategic developments. Examples include updates on the Ambler Access Project, where the company reports on federal right-of-way permits and presidential decisions under the Alaska National Interest Lands Conservation Act, and a binding letter of intent with the U.S. Department of War for a strategic investment intended to advance exploration and development of the UKMP. These filings outline key terms such as planned investments, warrant and option structures, board appointment rights and covenants on future indebtedness.
On Stock Titan, users can review these SEC filings as they are pulled from EDGAR in near real time and supported by AI-generated explanations that summarize the main points of lengthy legal documents. This includes highlighting the significance of new ATM programs, strategic investments, project permits and other disclosures that may affect Trilogy Metals’ exploration and development activities in the Ambler Mining District.
William L. Iggiagruk Hensley, a director of Trilogy Metals Inc. (TMQ), reported a non-discretionary grant of 7,672.368 Deferred Share Units (DSUs) on 09/02/2025. The DSUs were issued at $0 and vest immediately, but the underlying common shares are not issued and carry no voting or dispositive rights until the grantee’s service as a director ends. Following the grant, the reporting line shows beneficial ownership of 514,346.611 common shares. The DSUs expire no later than 90 days after the grantee’s termination. The Form 4 filing was signed on 09/03/2025 by an attorney-in-fact.
Trilogy Metals director William Beckwith received 6,920.175 deferred share units (DSUs) on 09/02/2025. The DSUs are non‑discretionary issuances under prior elections and vest immediately, but the underlying 6,920.175 common shares will not be issued and carry no voting or dispositive rights until Beckwith’s service terminates; grants expire no later than 90 days after termination. The transaction is recorded at a $0 price. After this issuance, Beckwith’s reported beneficial ownership of common shares stands at 480,392.366. The Form 4 was signed by an attorney‑in‑fact on 09/03/2025.
Trilogy Metals Inc. (TMQ) director James Gowans received 9,928.947 Deferred Share Units (DSUs) on 09/02/2025 as reported on Form 4. The filing states these DSUs were non-discretionary issuances under elections made by plan participants before the current fiscal year and they vest immediately. The DSUs carry no voting or dispositive rights and will not be converted into common shares until the grantee’s service or directorship ends; any issuance will occur within 90 days after termination. The report shows 560,141.362 common shares beneficially owned following the transaction. The form was signed by an attorney-in-fact on behalf of Mr. Gowans.